Fig. 2

Kaplan-Meier curves for overall survival according to TME protein expressions in endometrial carcinomas. a, patients with TCs expressing high PD-L1 (n = 74) vs. low PD-L1 (n = 147); b, patients with TICs expressing high PD-L1 (n = 36) vs. low PD-L1 (n = 185); c, patients with PD-1⁺ TICs of high density (n = 81) vs. low density (n = 140); d, patients with TCs expressing high VEGF (n = 151) vs. low VEGF (n = 70); e, patients with CD4⁺ TICs of high density (n = 92) vs. low density (n = 129); f, patients with CD8⁺ TICs of high density (n = 124) vs. low density (n = 97); g, patients with CD68⁺ TICs of high density (n = 105) vs. low density (n = 116); h, patients with MSI tumor (n = 48) vs. MSS tumor (n = 173); i, patients with TCs expressing low PD-L1 and TICs expressing high PD-L1 (n = 18) vs. the remaining patients (n = 203)